Tomas Blomquist – new CEO & President of Biotage
Contact persons:Torben Jörgensen, CEOTel: +46 707 49 05 84, torben.jorgensen@biotage.comThomas Eklund, Chairman of the BoardTel: +46 (0)708 24 20 25, thomas.eklund@investorab.comUppsala, Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at Abbott, will start his assignment on November 6, 2019, and will then take over the responsibility for the Biotage group and its + 400 employees. Tomas Blomquist has been in the Life Sciences